4 active warrant series; nearest expiry 2028-10-25.
Compare this book against every issuer →4 option grants covering 720,032 shares (~2.9% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $15.89 | Oct 25, 2028 759d | 84K | ITM | 0.3% | C$1.3M | Auto |
| option | $77.56 | May 3, 2029 949d | 46K | OTM | 0.2% | C$3.6M | Auto |
| option | $43.22 | Dec 15, 2029 1175d | 572K | OTM | 2.3% | C$24.7M | Auto |
| option | $9.96 | Mar 20, 2031 1635d | 19K | ITM | 0.1% | C$184K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
24,947,594 shares outstanding, plus 0 from warrants and 720,032 from options — a fully diluted 25,667,626 shares, or ~2.9% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
4 active warrant series; nearest expiry 2028-10-25.
Compare this book against every issuer →4 option grants covering 720,032 shares (~2.9% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $15.89 | Oct 25, 2028 759d | 84K | ITM | 0.3% | C$1.3M | Auto |
| option | $77.56 | May 3, 2029 949d | 46K | OTM | 0.2% | C$3.6M | Auto |
| option | $43.22 | Dec 15, 2029 1175d | 572K | OTM | 2.3% | C$24.7M | Auto |
| option | $9.96 | Mar 20, 2031 1635d | 19K | ITM | 0.1% | C$184K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
24,947,594 shares outstanding, plus 0 from warrants and 720,032 from options — a fully diluted 25,667,626 shares, or ~2.9% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
